Chris Martin (L) and new ADC Therapeutics CEO Ameet Mallik
Ameet Mallik finds greener turf as new head of ADC Therapeutics following ill-fated first CEO stint
Around a year ago, Ameet Mallik left his post at Novartis, where he had spent the last 16 years, to champion a drug for metastatic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
